BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32336417)

  • 21. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Xue T; Budde LE
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):575-587. PubMed ID: 32336421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
    Lucioni M; Novara F; Fiandrino G; Riboni R; Fanoni D; Arra M; Venegoni L; Nicola M; Dallera E; Arcaini L; Onida F; Vezzoli P; Travaglino E; Boveri E; Zuffardi O; Paulli M; Berti E
    Blood; 2011 Oct; 118(17):4591-4. PubMed ID: 21900200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Lane AA
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):589-600. PubMed ID: 32336422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
    Künstner A; Schwarting J; Witte HM; Xing P; Bernard V; Stölting S; Lohneis P; Janke F; Salehi M; Chen X; Kusch K; Sültmann H; Chteinberg E; Fischer A; Siebert R; von Bubnoff N; Merz H; Busch H; Feller AC; Gebauer N
    Leukemia; 2024 May; 38(5):1086-1098. PubMed ID: 38600314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
    Pemmaraju N; Gupta V; Thompson MA; Lane AA
    Curr Hematol Malig Rep; 2016 Dec; 11(6):462-467. PubMed ID: 27492117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
    Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
    Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-Biased
    Togami K; Chung SS; Madan V; Booth CAG; Kenyon CM; Cabal-Hierro L; Taylor J; Kim SS; Griffin GK; Ghandi M; Li J; Li YY; Angelot-Delettre F; Biichle S; Seiler M; Buonamici S; Lovitch SB; Louissaint A; Morgan EA; Jardin F; Piccaluga PP; Weinstock DM; Hammerman PS; Yang H; Konopleva M; Pemmaraju N; Garnache-Ottou F; Abdel-Wahab O; Koeffler HP; Lane AA
    Cancer Discov; 2022 Feb; 12(2):522-541. PubMed ID: 34615655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.
    Li Y; Sun V; Sun W; Pawlowska A
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):601-612. PubMed ID: 32336423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.
    Li M; Shah M; Binder M; Lasho T; Carr R; Mangaonkar A; Gangat N; Coltro G; Tefferi A; Dao L; Peters M; Chiu A; Patnaik MM
    Am J Hematol; 2020 Feb; 95(2):E31-E34. PubMed ID: 31705546
    [No Abstract]   [Full Text] [Related]  

  • 34. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R; Nabell L; Borak S; Peker D
    Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Suzuki K; Suzuki Y; Hama A; Muramatsu H; Nakatochi M; Gunji M; Ichikawa D; Hamada M; Taniguchi R; Kataoka S; Murakami N; Kojima D; Sekiya Y; Nishikawa E; Kawashima N; Narita A; Nishio N; Nakazawa Y; Iwafuchi H; Watanabe KI; Takahashi Y; Ito M; Kojima S; Kato S; Okuno Y
    Leukemia; 2017 Jul; 31(7):1629-1633. PubMed ID: 28344318
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.
    Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA
    Curr Hematol Malig Rep; 2017 Dec; 12(6):592-597. PubMed ID: 29064025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of blastic plasmacytoid dendritic cell neoplasm.
    Sullivan JM; Rizzieri DA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):16-23. PubMed ID: 27913457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.
    Wiesner T; Obenauf AC; Cota C; Fried I; Speicher MR; Cerroni L
    J Invest Dermatol; 2010 Apr; 130(4):1152-7. PubMed ID: 19924135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.